ZHEJIANG SHENGDA BIO-PHARM CO., L.../ CNE100002W43 /
17.05.2024 09:00:00 | Diff. +0,13 | Volumen | Geld09:00:03 | Brief09:00:03 | Tageshoch | Tagestief |
---|---|---|---|---|---|---|
12,26CNY | +1,07% | 6,47 Mio. Umsatz: 78,77 Mio. |
12,25Geld Vol: 16.800 | 12,26Brief Vol: 36.300 | 12,30 | 11,98 |
GlobeNewswire
14:00
Intercept Presents New Data Demonstrating the Impact of OCA-Bezafibrate Combination Therapy on ALP a...
GlobeNewswire
14:00
ValueZone's CEO Pledges to Lead in Cutting-Edge Quantitative Trading for Enhanced Passive Income
GlobeNewswire
13:00
MERGER INVESTIGATION NOTICE: Investor Protection Law Firm Kaskela Law LLC Announces Shareholder Inve...
GlobeNewswire
05:00
THOTIANA Launches Memecoin Presale with BONUS Airdrop Opportunity on Solana Network
GlobeNewswire
03:00
PALO ALTO NETWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Palo Alto Networks, Inc. on B...
GlobeNewswire
03:00
ACELYRIN ALERT: Bragar Eagel & Squire, P.C. is Investigating Acelyrin, Inc. on Behalf of Long-Term S...
GlobeNewswire
03:00
VERRICA ALERT: Bragar Eagel & Squire, P.C. is Investigating Verrica Pharmaceuticals, Inc. on Behalf ...
GlobeNewswire
03:00
UNITEDHEALTH ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed...
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite